Halozyme Therapeutics, INC.
U.S. Biotechnology Company
Based in CA
🤖
AI Overview
With $700K in lobbying spend across 27 quarterly filings, Halozyme Therapeutics, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2019 to 2025.
$700K
Total Spend
7
Years Active
1
Firms Hired
10
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $50K |
| 2020 | $30K |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $140K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Science/Technology, Budget/Appropriations
- •Issues related to the coverage of and reimbursement for novel drug delivery system and market uptake/access
- •Issues related to the coverage of and reimbursement for novel drug delivery system and market uptake/access.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.